InvestorsHub Logo
Followers 3422
Posts 32269
Boards Moderated 1
Alias Born 07/08/2006

Re: $heff post# 94216

Tuesday, 06/28/2016 12:52:40 PM

Tuesday, June 28, 2016 12:52:40 PM

Post# of 97237
$MRNS..$1.26..Two failed trials in a row is crushing their stock price.

Marinus reports primary endpoint not met in Phase 2 Fragile X Syndrome trial $MRNS: Full Story http://bit.ly/29k3sjs

Sheff's Station...All Aboard...Sign Up Here!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.